General Mills Reaffirms Full-Year Guidance as International Profit Jumps 14%. Is the Turnaround Finally Working?

General Mills reported fiscal Q1 2027 sales of $4.4 billion, down 3% year over year, and adjusted EPS of $0.75, modestly above consensus estimates of roughly $4.3 billion and $0.72. GAAP net income fell 67% to just over $398 million, primarily reflecting the prior-year gain of more than $1 billion from the U.S. yogurt-business sale. Management reaffirmed fiscal 2027 guidance for net sales of -1.5% to +0.5% and adjusted EPS of $3.00-$3.20, below the prior year's $3.55, while maintaining its $0.61 quarterly dividend yielding 6.8%.

Analysis

GIS is increasingly an income-duration equity rather than a credible growth re-rating candidate. The portfolio exits remove revenue but should modestly improve the quality of earnings; the key question is whether divestiture proceeds are directed to debt reduction rather than used to defend the payout or fund buybacks at an uncompetitive multiple. With domestic volumes still the weak link, price/mix can protect gross profit only temporarily before elasticity, retailer pushback, and private-label substitution pressure margins.

Near term, a modest earnings beat paired with unchanged guidance is unlikely to overcome the market's focus on the implied earnings decline. Over the next 1-3 months, scanner data on U.S. cereal, snacks, refrigerated dough and pet-food volume is the relevant catalyst; a second consecutive weak-volume print would likely force lower FY27 EPS expectations and widen GIS's valuation discount versus peers such as KHC and CPB. Conversely, sustained international profit growth could support estimates, but FX and emerging-market input-cost volatility make that a lower-quality offset.

The dividend yield is not itself a catalyst: a high payout in a shrinking earnings base raises the equity's sensitivity to rates and to free-cash-flow conversion. The contrarian bull case is that lower-growth assets have been sold, leverage falls, and remaining brands can stabilize volumes through innovation; this would permit a defensive multiple recovery. That thesis is falsified if organic U.S. sales remain negative through the next two quarters, adjusted EPS guidance moves below the current range, or management signals dividend funding requires incremental leverage.

Key Decisions for Investors

• Maintain an underweight/short bias in GIS for the next 1-3 months; use post-results strength to enter rather than chase weakness. Target a 8-12% relative underperformance versus XLP if U.S. volume fails to inflect by the next earnings release; cover on evidence of two consecutive quarters of positive organic volume growth.
• Pair trade: long KHC / short GIS, sized beta-neutral, over a 3-6 month horizon. KHC offers a more identifiable self-help and margin-reset pathway, while GIS remains exposed to volume-led estimate risk; exit if GIS raises full-year EPS guidance or KHC's organic sales trend deteriorates materially.
• Do not add GIS solely for yield until debt-paydown and free-cash-flow allocation following divestitures are disclosed. Set an alert for any payout-ratio deterioration, working-capital cash drain, or net-debt/EBITDA increase; each would elevate dividend-risk perception and could trigger a faster multiple de-rating.
• For defensive consumer-staples exposure, favor XLP rather than single-name GIS until category scanner data confirm stabilization. This preserves sector defensiveness while reducing exposure to an idiosyncratic guidance cut.